Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis

[1]  Yu Qin,et al.  Long Non-coding RNA JHDM1D-AS1 Interacts with DHX15 Protein to Enhance Non-Small-Cell Lung Cancer Growth and Metastasis , 2019, Molecular therapy. Nucleic acids.

[2]  Hengyu Mao.  Clinical relevance of mutant-allele tumor heterogeneity and lung adenocarcinoma. , 2019, Annals of translational medicine.

[3]  Minoru Kanehisa,et al.  New approach for understanding genome variations in KEGG , 2018, Nucleic Acids Res..

[4]  Xu Ma,et al.  Cell division cycle 20 promotes cell proliferation and invasion and inhibits apoptosis in osteosarcoma cells , 2018, Cell cycle.

[5]  Gang Chen,et al.  Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[6]  C. la Vecchia,et al.  European cancer mortality predictions for the year 2017, with focus on lung cancer , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[8]  Haitao Zhao,et al.  Mps1/TTK: a novel target and biomarker for cancer , 2017, Journal of drug targeting.

[9]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[10]  L. Vreede,et al.  Prevalence of germline mutations in the spindle assembly checkpoint gene BUB1B in individuals with early‐onset colorectal cancer , 2016, Genes, chromosomes & cancer.

[11]  Nina Kočevar Britovšek,et al.  Association between polymorphisms in segregation genes BUB1B and TTK and gastric cancer risk. , 2016, Radiology and oncology.

[12]  A. Sayad,et al.  Targeting of BUB1b Gene Expression in Sentinel Lymph Node Biopsies of Invasive Breast Cancer in Iranian Female Patients. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[13]  Ruth C Lovering,et al.  Exploring autophagy with Gene Ontology , 2016, Autophagy.

[14]  Wei-De Zhong,et al.  Oncotargets and Therapy Dovepress Dovepress Overexpression of Bub1b Contributes to Progression of Prostate Cancer and Predicts Poor Outcome in Patients with Prostate Cancer , 2022 .

[15]  Jian Huang,et al.  TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells , 2015, Oncotarget.

[16]  Chiara Benedetto,et al.  Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis , 2015, PloS one.

[17]  Tim A. Hoek,et al.  Dissecting the roles of human BUB1 in the spindle assembly checkpoint , 2015, Journal of Cell Science.

[18]  R. Medema,et al.  Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  A. Fusco,et al.  Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors , 2015, Cell cycle.

[20]  A. Namboodiri,et al.  Higher levels of antibodies to the tumour‐associated antigen cyclin B1 in cancer‐free individuals than in patients with breast cancer , 2014, Clinical and experimental immunology.

[21]  Weixun Zhou,et al.  The prognostic value of Cyclin B1 in pancreatic cancer , 2014, Medical Oncology.

[22]  Dan-dan Wang,et al.  Expression and Function Analysis of Mitotic Checkpoint Genes Identifies TTK as a Potential Therapeutic Target for Human Hepatocellular Carcinoma , 2014, PloS one.

[23]  T. Lagerweij,et al.  Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs. , 2013, Journal of the National Cancer Institute.

[24]  L. Galluzzi,et al.  Characterization of novel MPS1 inhibitors with preclinical anticancer activity , 2013, Cell Death and Differentiation.

[25]  L. Staudt,et al.  Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma. , 2012, Cancer Research.

[26]  Sven Laur,et al.  Robust rank aggregation for gene list integration and meta-analysis , 2012, Bioinform..

[27]  Dennis B. Troup,et al.  NCBI GEO: archive for functional genomics data sets—10 years on , 2010, Nucleic Acids Res..

[28]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2011 , 2010, Nucleic Acids Res..

[29]  F. Marincola,et al.  Gene-expression profiling in vaccine therapy and immunotherapy for cancer , 2010, Expert review of vaccines.

[30]  S. Chuang,et al.  The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells , 2010, Molecular carcinogenesis.

[31]  Y. Ko,et al.  Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[32]  A. Xu,et al.  The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma , 2009, Journal of Clinical Pathology.

[33]  J. Glasner,et al.  Gene Ontology annotation highlights shared and divergent pathogenic strategies of type III effector proteins deployed by the plant pathogen Pseudomonas syringae pv tomato DC3000 and animal pathogenic Escherichia coli strains , 2009, BMC Microbiology.

[34]  M. Lenburg,et al.  Clinical Impact of High-Throughput Gene Expression Studies in Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[35]  B. Coe,et al.  Evolving strategies for global gene expression analysis of cancer , 2008, Journal of cellular physiology.

[36]  C. Sotiriou,et al.  Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? , 2007, Nature Reviews Cancer.

[37]  E. Barillot,et al.  APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation. , 2007, Gastroenterology.

[38]  P. Carbon,et al.  Transcription of the human cell cycle regulated BUB1B gene requires hStaf/ZNF143 , 2007, Nucleic acids research.

[39]  S. Inoue,et al.  Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor , 2007, Cancer science.

[40]  Akhilesh Pandey,et al.  Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags , 2004, Cancer biology & therapy.

[41]  K. Strebhardt,et al.  Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells , 2004, Oncogene.

[42]  R. Kumar,et al.  BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice , 2004, Nature Genetics.

[43]  Keith M. Kerr,et al.  Gene Expression Profiling in Non-Small Cell Lung Cancer , 2004, Clinical Cancer Research.

[44]  Hongtao Yu,et al.  The spindle checkpoint, aneuploidy, and cancer , 2004, Oncogene.

[45]  S. Takeno,et al.  Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma , 2002, Cancer.

[46]  R. Benezra,et al.  Identification of a Human Mitotic Checkpoint Gene: hsMAD2 , 1996, Science.

[47]  Walid G. Aref,et al.  Exploring , 2009, Encyclopedia of Database Systems.

[48]  Liying Wang,et al.  Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cells. , 2012, Toxicology and applied pharmacology.

[49]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.